Connect with others who understand.

sign up log in
About MyParkinsonsTeam

Parkinson’s Disease and Parkinsonism – An Overview

Posted on August 13, 2018
Article written by
Kelly Crumrin

Parkinsonism is a syndrome, or collection of symptoms and signs, characterized by bradykinesia (slowed movements), tremors, loss of balance, and stiffness. The most common type of parkinsonism is Parkinson’s disease, which accounts for about 80 percent of cases. Other types of parkinsonism include drug-induced parkinsonism, multiple system atrophy (MSA), progressive supranuclear palsy (PSP), vascular parkinsonism, dementia with Lewy bodies (DLB), and corticobasal degeneration (CBD). Read more about types of parkinsonism.

Parkinson’s disease and other types of parkinsonism are chronic diseases of the brain and spinal cord, also referred to as the central nervous system or CNS. Parkinson’s can be treated, but there is no cure. Symptoms vary among people with Parkinson’s, but motor (movement) and cognitive problems are among the most common. Parkinson’s symptoms worsen over time, gradually becoming debilitating and causing severe disability. Parkinson’s is not fatal, and on average, people with Parkinson’s have similar lifespans as people without Parkinson’s.

What Is Parkinson’s?

Deep inside the brain, regions called the basal ganglia and substantia nigra work together to ensure that the body moves smoothly. The substantia nigra produces a neurotransmitter – a chemical that helps nerves communicate – called dopamine. Messages sent by the brain to muscles to cause movement pass through the basal ganglia with the help of dopamine. In parkinsonism, cells in the substantia nigra gradually stop producing dopamine and die off. With too little dopamine, the basal ganglia cannot facilitate movement as well. Researchers believe parkinsonian symptoms begin when the level of dopamine falls to about half of normal levels.

Other parts of the brain try to compensate for the lack of dopamine, resulting in more dysfunction.

What Causes Parkinson’s?

Different types of parkinsonism can have different causes. Some people have a strong family history of Parkinson’s, and genetics play a role. Others develop parkinsonism after taking certain psychiatric, anti-nausea, or illegal recreational drugs. For most people, Parkinson’s is most likely caused by a combination of inherited predisposition and environmental risk factors such as head injuries and exposure to radiation or toxins. Read more about causes of Parkinson’s.

The History of Parkinson’s

As early as 600 BCE, medical texts from India described the symptoms of Parkinson’s disease. Ayurvedic (traditional Indian medicine) doctors prescribed powdered seeds of the velvet bean, which may have been effective – the bean contains a small amount of Levodopa, the most common treatment for Parkinson’s today. In Ayurveda, Parkinson’s is called kampavata, from the Sanskrit kampa, meaning “shaking,” and vata, meaning “lack of muscular movement.” In the West, Greek physician Galen described cases of “shaking palsy” as early as 175 CE.

In 1817, English doctor James Parkinson published "An Essay on the Shaking Palsy," in which he described cases of movement disorders he treated in his practice and witnessed among London citizens. Parkinson recommended bloodletting and inducing blisters on the neck as treatment. From 1868 to 1881, French neurologist Jean-Marie Charcot completed several studies that helped define the condition. Charcot also promoted the naming of the disease for Dr. Parkinson. Charcot and his team published papers recommending two plant-based drugs, belladonna and hyoscyamine, as treatments for parkinsonism. These 19th century medications are in the anticholinergic and muscarinic antagonist classes of drugs respectively; other drugs in these classes are still used to treat Parkinson’s.

German neurologist Friedrich Lewy discovered abnormal “spherical inclusions” in 1912 during autopsies of people who died with Parkinson’s disease. Now known as Lewy bodies, these deposits of alpha-synuclein (aS) protein are understood to be one of the most common causes of dementia in people with parkinsonism.

Starting in the 1950s, researchers began to learn more about the neurotransmitter dopamine, where it is made in the brain, and its role in motor and cognitive functions. This research led to the discovery that Parkinson’s was caused by dopamine loss. This led to the realization that Levodopa increased dopamine, making it a good prospective treatment for Parkinson’s. Levodopa was first given to people with Parkinson’s in 1961 and immediately proved extremely effective. Levodopa remains the gold standard of Parkinson’s treatment.

Since the 1990s, scientists have found several genes associated with the development of Parkinson’s. In 2002, deep brain stimulation was approved to treat Parkinson’s by the U.S. Food and Drug Administration (FDA). Experiments transplanting stem cells to produce dopamine have been promising, and clinical trials are underway to test the safety and effectiveness of this treatment.

How Common Is Parkinson’s?

Approximately 10 million people around the world and more than 1 million in the United States have Parkinson’s disease. Close to 1 percent of the population over age 60 will develop Parkinson’s. About 60,000 new cases are diagnosed in the U.S. each year. Parkinson’s is typically diagnosed between the ages of 40 and 70, with the majority of people diagnosed in their 70s. Only about 4 percent of Parkinson’s disease cases are diagnosed before age 50; rarely, Parkinson’s has been diagnosed in people as young as 18.

How Does Parkinson’s Progress?

Everyone diagnosed with Parkinson’s disease experiences disease progression. Some types of parkinsonism and some individuals progress more quickly than others. People with Parkinson’s can experience different symptoms at different intensities, and earlier or later in the course of the disease. There are five stages of Parkinson’s that describe the most typical pattern of progression from mild motor symptoms that gradually worsen to cause increasing levels of disability. Some people experience cognitive symptoms with Parkinson’s that also worsen over time.

Parkinson’s disease is not a fatal condition. For the most part, people with Parkinson’s have similar longevity as people without Parkinson’s. Parkinson’s can shorten the life span by about two years on average due to an increased risk of falls and pneumonia from aspirated (inhaled) food. According to one study, the risk of an earlier death differs between types of parkinsonism:

  • Multiple system atrophy — 6 years earlier than average
  • Lewy body dementia — 4 years earlier than average
  • Parkinson disease with dementia — 3.5 years earlier than average
  • Parkinson disease without dementia — 1 year earlier than average

Most people with parkinsonism die of the same conditions other people die of, such as cancer, stroke, and heart disease.

Condition Guide

References

  1. Parkinson's Disease & Parkinsonism — International Parkinson and Movement Disorder Society
  2. Parkinson’s Disease (PD) — Merck Manual
  3. Statistics — Parkinson’s Foundation
  4. Parkinson’s Disease Causes — Michael J. Fox Foundation
  5. Stages of Parkinson’s — Parkinson’s Foundation
  6. Types of Parkinson's and Parkinsonism — European Parkinson’s Disease Foundation
  7. Diagnosing Parkinson’s — American Parkinson Disease Association
  8. Study Offers Answers on Life Expectancy for People With Parkinson's disease, Lewy Body Dementia — Northwest Parkinson’s Foundation
  9. Parkinson’s Disease Prognosis — Michael J. Fox Foundation
  10. Death in Parkinson’s Disease — American Parkinson’s Disease Association
  11. Parkinson’s Disease (PD) — Mayfield Brain & Spine
  12. Parkinson’s Disease — Mayo Clinic
  13. The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies — Cold Spring Harbor Perspectives in Medicine
  14. Is Parkinson’s Disease Contagious? — Stop Parkinson’s
  15. Intramuscular Injection of α-synuclein Induces CNS α-synuclein Pathology and a Rapid-Onset Motor Phenotype in Transgenic Mice — Proceedings of the National Academy of Sciences
  16. Progressive Supranuclear Palsy Fact Sheet — National Institute of Neurological Disorders and Stroke


Kelly Crumrin leads the creation of content that educates and empowers people with chronic illnesses. Learn more about her here.

A MyParkinsonsTeam Member said:

Dear Margie, I'm not sure how long I will have my care giver. You
may want to check with social services or perhaps a hospital could help you out. Sorry I don't have any more information. But good… read more

posted 5 days ago

hug

Recent articles

If you have Parkinson’s disease (PD), you may be curious about the role vitamin D plays in your...

Vitamin D and Parkinson’s: Benefits and Uses

If you have Parkinson’s disease (PD), you may be curious about the role vitamin D plays in your...
To determine how you can reduce your medical expenses, MyParkinsonsTeam sat down with Susan Null...

How To Reduce Medical Bills: Top Financial Expert Shares 10 Tips

To determine how you can reduce your medical expenses, MyParkinsonsTeam sat down with Susan Null...
If you have Parkinson’s disease (PD), you may be wondering whether alcohol consumption affects...

Parkinson’s Disease and Alcohol: Your Guide

If you have Parkinson’s disease (PD), you may be wondering whether alcohol consumption affects...
If you or a loved one is living with Parkinson’s disease (PD), you’ve probably spent a lot of...

5 Facts About Parkinson's That Aren't Well Known

If you or a loved one is living with Parkinson’s disease (PD), you’ve probably spent a lot of...
We all respond differently to information about our health. After learning you have Parkinson’s...

What MyParkinsonsTeam Members Would Tell Those Who Have Just Been Diagnosed

We all respond differently to information about our health. After learning you have Parkinson’s...
As of June 10, more than 63 percent of Americans had received at least their first vaccination...

Life After COVID-19 Vaccination: What Are MyParkinsonsTeam Members Doing Now That They’re Vaccinated?

As of June 10, more than 63 percent of Americans had received at least their first vaccination...
Most cases of Parkinson’s disease (PD) occur due to an unknown cause. Although researchers know...

Quiz: Do You Know the Causes of Parkinson’s Disease?

Most cases of Parkinson’s disease (PD) occur due to an unknown cause. Although researchers know...
Because the physical impact of Parkinson's disease can be all-consuming, you may be dealing with...

How Parkinson’s Disease Can Affect Your Mental Health

Because the physical impact of Parkinson's disease can be all-consuming, you may be dealing with...
Dyskinesia and dystonia are common conditions that develop in people with Parkinson’s disease and...

Dyskinesia vs. Dystonia: Understanding the Difference

Dyskinesia and dystonia are common conditions that develop in people with Parkinson’s disease and...
Dopamine is a specialized chemical messenger responsible for sending signals in the brain to...

Understanding Dopamine and Parkinson’s Disease

Dopamine is a specialized chemical messenger responsible for sending signals in the brain to...
MyParkinsonsTeam My Parkinson's disease Team

Two Ways to Get Started with MyParkinsonsTeam

Become a Member

Connect with others who are living with Parkinson's disease. Get members only access to emotional support, advice, treatment insights, and more.

sign up

Become a Subscriber

Get the latest articles about Parkinson's disease sent to your inbox.

Not now, thanks

Privacy policy
MyParkinsonsTeam My Parkinson's disease Team

Thank you for signing up.

close